z-logo
Premium
Pharmacological profile of the ATP‐mediated increase in L‐type calcium current amplitude and activation of a non‐specific cationic current in rat ventricular cells
Author(s) -
Scamps Frédérique,
Vassort Guy
Publication year - 1994
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1111/j.1476-5381.1994.tb17089.x
Subject(s) - suramin , chemistry , adenosine triphosphate , potency , biophysics , purinergic receptor , beta (programming language) , biochemistry , biology , receptor , in vitro , computer science , programming language
1 The pharmacological profile of the ATP‐induced increase in I Ca amplitude and of ATP activation of a non‐specific cationic current, I ATP , was investigated in rat ventricular cells. 2 The EC 50 values for I Ca increase and I ATP activation were 0.36 μ m and 0.76 μ m respectively. Suramin (10 μ m ) and cibacron blue (1 μ m ) competitively antagonized both effects of ATP. 3 The rank order of efficacy and potency of ATP analogues in increasing I Ca amplitude was 2‐methylthio‐ATP ≅ ATP ≅ ATPγS. The derivatives α,β‐methylene‐ATP, β,γ‐methylene‐ATP and β,γ‐imido‐ATP up to 500 μ m had no significant effects. 4 The rank order of efficacy of ATP analogues in activating a non‐specific cationic current, I ATP , was 2‐methylthio‐ATP > ATP > > ATPγS. The rank order of potency was 2‐methylthio‐ATP ≅ ATP. The EC 50 of ATPγS could not be determined owing to its very low efficacy. 5 The ATP analogues α,β‐methylene‐ATP, β,γ‐methylene‐ATP and β,γ‐imido‐ATP at 500 μ m did not activate I ATP but acted as antagonists of activation of I ATP by ATP. 6 The results suggest that the increase in I Ca amplitude induced by external ATP is due to activation of P 2Y ‐purinoceptors. 7 The mechanism of I ATP activation remains to be determined before the receptor subtype involved can be deduced.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here